Figure 2.
Prognosis analysis of miR-93-5p and miR-18a on prognosis of NSCLC patients. A: 4-year survival analysis of patients with high and low expression of miR-93-5p; B: 4-year survival analysis of patients with high and low expression of miR-18a.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.